U.S. Electric Utilities Stock News

Albany International has reported that its Albany Engineered Composites segment achieved U.S. Department of War Cybersecurity Maturity Model Certification Level 2, confirming its eligibility as a supplier for sensitive fixed-wing, hypersonic, missile, and rotorcraft programs. This certification deepens Albany’s role in the national security supply chain, potentially reinforcing its defense-related composites business as a core long-term revenue pillar. We’ll now examine how Albany’s new CMMC...

XPO, Inc. is shaking up its boardroom, with founder Brad Jacobs stepping down as Executive Chairman and CEO Mario Harik assuming the Chairman role. This shift puts leadership focus and strategic continuity squarely in the spotlight for investors. See our latest analysis for XPO. The leadership reshuffle lands at a time when XPO’s 1 month share price return of 6.60 percent and year to date share price return of 6.63 percent suggest moderate but positive momentum. A three year total shareholder...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Simmons First National recently reported quarterly revenue of US$236.3 million, a 12.7% year-on-year increase that surpassed analyst expectations by 1.2%, although earnings per share only matched forecasts and tangible book value per share fell short. This mix of strong top-line momentum and softer profitability metrics highlights how the bank is capturing higher revenues while still contending with margin and balance-sheet pressures common across regional lenders. We’ll now examine how this...

The FDA approval of MYQORZO for obstructive hypertrophic cardiomyopathy has initiated Royalty Pharma (RPRX)'s royalty stream and repayment terms, a material catalyst that strengthens its long-term cash flow profile. See our latest analysis for Royalty Pharma. This latest FDA milestone lands on top of a strong run, with the share price up 50.68 percent year to date and a 12 month total shareholder return of 57.78 percent. This suggests momentum is building as investors reassess Royalty...

In recent days, OceanFirst Financial has attracted increased attention after DA Davidson, Keefe, Bruyette & Woods, and Raymond James all raised their ratings on the bank to more positive levels. This rare clustering of upgrades from multiple research houses highlights a growing conviction in OceanFirst’s business trajectory and risk profile among professional analysts. We’ll now examine how this wave of analyst upgrades might reshape OceanFirst Financial’s investment narrative, especially...

Distribution Solutions Group (DSGR) just secured a larger, extended credit facility running through 2030, increasing both its term debt and revolving credit, and effectively giving management more flexibility to fund future growth initiatives. See our latest analysis for Distribution Solutions Group. Even with the expanded credit facility hinting at bolder growth plans, the stock has been under pressure, with a weak year to date share price return but still a solid three year total...

Flowserve Corporation ( NYSE:FLS ) stock is about to trade ex-dividend in 2 days. The ex-dividend date occurs one day...

Avis Budget Group recently reported that it has not increased available rental days over the past two years, while its return on invested capital has fallen and debt-fueled cash burn has intensified, raising fresh concern about demand and capital efficiency. Taken together, these trends point to a business struggling to find profitable growth opportunities in a potentially saturated market, with balance sheet pressure heightening the risk profile for investors. We’ll now examine how Avis...

How Quest Diagnostics Stock Has Been Performing Quest Diagnostics (DGX) has quietly outpaced many healthcare peers over the past year, with the stock up about 17% and a solid 64% gain over the past 5 years. That kind of long term compounding, backed by steady revenue and net income growth, makes Quest interesting for investors who prefer durable cash flows rather than story driven momentum. See our latest analysis for Quest Diagnostics. In the near term, the 1 month share price return of...

Paychex (PAYX) just checked several important boxes at once, with Q2 revenue jumping in the high teens, the Paycor acquisition pulling its weight, and management lifting its adjusted EPS growth outlook for fiscal 2026. See our latest analysis for Paychex. Even with today’s jump to a share price of $114.88 and a 1 month share price return of 3.07%, Paychex is still working off a softer patch. The year to date share price return of minus 17.05% and a 1 year total shareholder return of minus...

Earlier this month, Charles Schwab announced a wave of enhancements across Schwab.com, Schwab Mobile, and thinkorswim, adding richer research tools, more flexible options trading workflows, portfolio tax-lot controls, and new futures contracts including 1 OZ Gold and Solana products to better serve its increasingly active retail traders. The upgrades, paired with Schwab’s expanding branch support network and focus on a comprehensive trading ecosystem, underline how the firm is using...

Despite an already strong run, HUHUTECH International Group Inc. ( NASDAQ:HUHU ) shares have been powering on, with a...

In December 2025, Wasatch BioLabs announced a co-marketing agreement with Agilent Technologies to pair Agilent’s SureSelect and Avida enrichment chemistries with WBL’s Oxford Nanopore-based Direct Targeted Methylation Sequencing platform, enabling precise, custom native-read targeting of genomic and cell-free DNA for research and clinical applications. The collaboration aims to broaden access to scalable, cost-efficient native-read multi-omic assays, especially for liquid biopsy, oncology,...

In December 2025, MarketAxess Holdings Inc. announced a new share repurchase program authorizing the buyback of up to US$400 million of its stock, signaling a major capital allocation move by the electronic bond-trading platform. This buyback plan highlights management’s confidence in the company’s long-term cash generation and may amplify the impact of any future earnings growth on each remaining share. Next, we’ll assess how MarketAxess’s US$400 million buyback authorization could reshape...

In recent years, IDEX’s organic revenue growth has trailed sector benchmarks, while earnings per share have fallen even as overall revenue increased. This combination of weaker organic momentum, less profitable incremental sales, and diminishing returns on capital raises questions about the durability of IDEX’s profit engine. We’ll now explore how weakening organic growth and declining earnings efficiency may affect IDEX’s previously growth-focused investment narrative. The end of cancer?...

As the U.S. stock market continues its upward momentum, with major indexes like the S&P 500 and Dow Jones Industrial Average nearing record highs, investors are keenly observing small-cap stocks for potential opportunities. In this environment of rising tech shares and record-breaking precious metal prices, identifying undervalued small-cap companies with insider buying can be a strategic move to capitalize on market dynamics.

Cardinal Health (CAH) just delivered a quarter that topped revenue expectations and showed solid operational momentum, and the stock’s recent strength suggests investors are leaning into that story ahead of the next earnings update. See our latest analysis for Cardinal Health. That upbeat earnings print fits into a powerful run, with the share price at $205.2 after a strong 90 day share price return of 32.71% and a five year total shareholder return of 334.33%, signaling momentum that...

As of December 2025, the U.S. stock market has been experiencing a positive trend with major indices like the S&P 500 and Dow Jones Industrial Average nearing record highs, driven largely by advances in tech shares and AI-related stocks. In this climate of robust technological growth, identifying high-growth tech stocks involves looking for companies that not only capitalize on emerging technologies but also demonstrate resilience and adaptability amidst evolving market dynamics.

As the U.S. stock market continues to rally, with major indexes like the S&P 500 and Dow Jones nearing record highs, investors are increasingly looking for opportunities in less traditional areas. Penny stocks, though often considered a relic of past market trends, remain a compelling option for those seeking growth potential at lower price points. These stocks typically represent smaller or newer companies and can offer significant upside when backed by strong financial health and solid...

Despite an already strong run, Sigma Lithium Corporation ( NASDAQ:SGML ) shares have been powering on, with a gain of...

The Lamb Weston Holdings, Inc. ( NYSE:LW ) share price has fared very poorly over the last month, falling by a...

The UiPath Inc. ( NYSE:PATH ) share price has done very well over the last month, posting an excellent gain of 28%. The...

Roadzen, Inc. ( NASDAQ:RDZN ) shares have continued their recent momentum with a 28% gain in the last month alone. Not...